Cargando…

Increasing Clinical Virulence in Two Decades of the Italian HIV Epidemic

The recent origin and great evolutionary potential of HIV imply that the virulence of the virus might still be changing, which could greatly affect the future of the pandemic. However, previous studies of time trends of HIV virulence have yielded conflicting results. Here we used an established meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Viktor, Maggiolo, Franco, Suter, Fredy, Ladisa, Nicoletta, De Luca, Andrea, Antinori, Andrea, Sighinolfi, Laura, Quiros-Roldan, Eugenia, Carosi, Giampiero, Torti, Carlo
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682199/ https://www.ncbi.nlm.nih.gov/pubmed/19478880 http://dx.doi.org/10.1371/journal.ppat.1000454

Ejemplares similares

Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort
por: Postorino, Maria Concetta, et al.
Publicado: (2017)

Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function
por: Postorino, Maria Concetta, et al.
Publicado: (2016)

The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study
por: Raffetti, Elena, et al.
Publicado: (2015)

Survival in HIV-Infected Patients after a Cancer Diagnosis in the cART Era: Results of an Italian Multicenter Study
por: Gotti, Daria, et al.
Publicado: (2014)

The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort
por: Raffetti, Elena, et al.
Publicado: (2016)

Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study
por: Raffetti, Elena, et al.
Publicado: (2017)

Efficacy, Convenience, Safety and Durability of DTG-Based Antiretroviral Therapies: Evidence from a Prospective Study by the Italian MaSTER Cohort
por: Fusco, Paolo, et al.
Publicado: (2023)

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort
por: Torti, Carlo, et al.
Publicado: (2005)

Convenience, efficacy, safety, and durability of INSTI-based antiretroviral therapies: evidence from the Italian MaSTER cohort
por: Rich, Shannan N., et al.
Publicado: (2023)

Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART
por: Lapadula, Giuseppe, et al.
Publicado: (2015)

Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy)
por: Izzo, Ilaria, et al.
Publicado: (2011)

One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects
por: Airoldi, Monica, et al.
Publicado: (2010)

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received
por: Motta, Davide, et al.
Publicado: (2012)

Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study
por: Focà, Emanuele, et al.
Publicado: (2016)

Liver fibrosis: concordance analysis between APRI and FIB-4 scores, evolution and predictors in a cohort of HIV patients without HCV and HBV infection
por: Mendeni, M, et al.
Publicado: (2010)

Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment
por: Lapadula, Giuseppe, et al.
Publicado: (2016)

Efavirenz: a decade of clinical experience in the treatment of HIV
por: Maggiolo, Franco
Publicado: (2009)

Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study
por: Raffetti, Elena, et al.
Publicado: (2015)

Correlates of Treatment and Disease Burden in People Living with HIV (PLHIV) in Italy
por: Cingolani, Antonella, et al.
Publicado: (2022)

Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003–2012 decade in Italy
por: Franzetti, Marco, et al.
Publicado: (2014)

Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: a multicenter retrospective cohort study from 2007 to 2015
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2018)

A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial)
por: Izzo, I, et al.
Publicado: (2010)

Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI
por: Torti, Carlo, et al.
Publicado: (2011)

Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection–Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study
por: Muscatello, Antonio, et al.
Publicado: (2020)

A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients()
por: Puoti, Massimo, et al.
Publicado: (2004)

A 2021 Update on Syphilis: Taking Stock from Pathogenesis to Vaccines
por: Tiecco, Giorgio, et al.
Publicado: (2021)

Effects of combined antiretroviral therapy on B- and T-cell release from production sites in long-term treated HIV-1(+) patients
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2012)

Prospective evaluation of bone markers, parathormone and 1,25-(OH)(2 )vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz
por: Focà, Emanuele, et al.
Publicado: (2012)

Lymphocyte homeostasis is maintained in perinatally HIV-infected patients after three decades of life
por: Paghera, S., et al.
Publicado: (2019)

Omicron BA.2 Lineage, the “Stealth” Variant: Is It Truly a Silent Epidemic? A Literature Review
por: Tiecco, Giorgio, et al.
Publicado: (2022)

An Epidemic of Virulent Diphtheria
por: Aubrey, Thomas, et al.
Publicado: (1929)

Smoking Habits among Italian Adolescents: What Has Changed in the Last Decade?
por: Charrier, Lorena, et al.
Publicado: (2014)

The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study
por: Raffetti, Elena, et al.
Publicado: (2015)

Emergence of Exhausted B Cells in Asymptomatic HIV-1-Infected Patients Naïve for HAART is Related to Reduced Immune Surveillance
por: Fogli, Manuela, et al.
Publicado: (2012)

Sex differences in a cohort of COVID-19 Italian patients hospitalized during the first and second pandemic waves
por: Quaresima, Virginia, et al.
Publicado: (2021)

Negative nasopharyngeal swabs in COVID-19 pneumonia: the experience of an Italian Emergency Department (Piacenza) during the first month of the Italian epidemic
por: Poggiali, Erika, et al.
Publicado: (2020)

Correction to: Sex differences in a cohort of COVID-19 Italian patients hospitalized during the first and second pandemic waves
por: Quaresima, Virginia, et al.
Publicado: (2021)

Evolution of Virulence in Emerging Epidemics
por: Berngruber, Thomas W., et al.
Publicado: (2013)

An Italian sacrifice to the COVID-19 epidemic
por: Nava, Stefano, et al.
Publicado: (2020)

Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice
por: Costarelli, Silvia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_24hcn9g9bp6kuqma5pbc225md0